Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2023-02-21 17:18:34 UTC |
---|
HMDB ID | HMDB0015687 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Salicylamide |
---|
Description | Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies |
---|
Structure | InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10) |
---|
Synonyms | Value | Source |
---|
2-Carbamoylphenol | ChEBI | 2-Carboxamidophenol | ChEBI | 2-Hydroxybenzamide | ChEBI | O-Hydroxybenzamide | ChEBI | OHB | ChEBI | Salicilamida | ChEBI | Salicylamidum | ChEBI | Salicylic acid amide | ChEBI | Salicylate amide | Generator | Salicylamide sulfate | HMDB | Salicylamide, 3H-labeled | HMDB | Salicylamide, monosodium salt | HMDB | Salicylamide, calcium (2:1) salt | HMDB | Salicylamide sodium | HMDB |
|
---|
Chemical Formula | C7H7NO2 |
---|
Average Molecular Weight | 137.136 |
---|
Monoisotopic Molecular Weight | 137.047678473 |
---|
IUPAC Name | 2-hydroxybenzamide |
---|
Traditional Name | salicylamide |
---|
CAS Registry Number | 65-45-2 |
---|
SMILES | NC(=O)C1=CC=CC=C1O |
---|
InChI Identifier | InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10) |
---|
InChI Key | SKZKKFZAGNVIMN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1-hydroxy-4-unsubstituted benzenoids. These are phenols that are unsubstituted at the 4-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenols |
---|
Sub Class | 1-hydroxy-4-unsubstituted benzenoids |
---|
Direct Parent | 1-hydroxy-4-unsubstituted benzenoids |
---|
Alternative Parents | |
---|
Substituents | - 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Monocyclic benzene moiety
- Carboximidic acid derivative
- Carboximidic acid
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Salicylamide,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC=C1C(N)=O | 1551.9 | Semi standard non polar | 33892256 | Salicylamide,1TMS,isomer #2 | C[Si](C)(C)NC(=O)C1=CC=CC=C1O | 1517.3 | Semi standard non polar | 33892256 | Salicylamide,2TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1O[Si](C)(C)C | 1656.6 | Semi standard non polar | 33892256 | Salicylamide,2TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1O[Si](C)(C)C | 1672.6 | Standard non polar | 33892256 | Salicylamide,2TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1O[Si](C)(C)C | 1739.3 | Standard polar | 33892256 | Salicylamide,2TMS,isomer #2 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1O)[Si](C)(C)C | 1557.0 | Semi standard non polar | 33892256 | Salicylamide,2TMS,isomer #2 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1O)[Si](C)(C)C | 1666.0 | Standard non polar | 33892256 | Salicylamide,2TMS,isomer #2 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1O)[Si](C)(C)C | 1885.1 | Standard polar | 33892256 | Salicylamide,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 1680.6 | Semi standard non polar | 33892256 | Salicylamide,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 1706.8 | Standard non polar | 33892256 | Salicylamide,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 1730.0 | Standard polar | 33892256 | Salicylamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC=C1C(N)=O | 1791.6 | Semi standard non polar | 33892256 | Salicylamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1O | 1765.2 | Semi standard non polar | 33892256 | Salicylamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1O[Si](C)(C)C(C)(C)C | 2104.4 | Semi standard non polar | 33892256 | Salicylamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1O[Si](C)(C)C(C)(C)C | 2093.2 | Standard non polar | 33892256 | Salicylamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1O[Si](C)(C)C(C)(C)C | 2052.7 | Standard polar | 33892256 | Salicylamide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1O)[Si](C)(C)C(C)(C)C | 2044.0 | Semi standard non polar | 33892256 | Salicylamide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1O)[Si](C)(C)C(C)(C)C | 2050.3 | Standard non polar | 33892256 | Salicylamide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1O)[Si](C)(C)C(C)(C)C | 2077.8 | Standard polar | 33892256 | Salicylamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2341.8 | Semi standard non polar | 33892256 | Salicylamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2328.1 | Standard non polar | 33892256 | Salicylamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2120.3 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Salicylamide EI-B (Non-derivatized) | splash10-00du-4900000000-f5a22e5a4fb556796bd9 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Salicylamide EI-B (Non-derivatized) | splash10-00du-8900000000-701c75263149bd35390b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Salicylamide EI-B (Non-derivatized) | splash10-00du-4900000000-f5a22e5a4fb556796bd9 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Salicylamide EI-B (Non-derivatized) | splash10-00du-8900000000-701c75263149bd35390b | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Salicylamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-00dr-5900000000-34487b27347166b47c91 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Salicylamide GC-MS (1 TMS) - 70eV, Positive | splash10-00dl-7910000000-4ceac10899bc2bd84993 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Salicylamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide , negative-QTOF | splash10-000i-1900000000-132217380eb9a2784eb0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 20V, Positive-QTOF | splash10-00di-5900000000-3514f0541f3795f71dbf | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 0V, Positive-QTOF | splash10-0079-0900000000-1332c56ba9ac3ef8d855 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 30V, Positive-QTOF | splash10-014i-9100000000-e954a1393b3fa6e55e25 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-00di-0900000000-7f2d4c95dfd91bbee7f2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 40V, Positive-QTOF | splash10-014i-9000000000-0badfa3dbe56d85736f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 30V, Negative-QTOF | splash10-00ku-2900000000-7255c4dc6adcdac743f0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 0V, Positive-QTOF | splash10-0079-0900000000-9644e91722b6cf633110 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 15V, Negative-QTOF | splash10-00ku-2900000000-c7ad1b72adf39d15c9c5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-00di-6900000000-7f24ecf80bd35bb96d6a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-00dr-0900000000-bc7caaa9243e4e46391b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 30V, Negative-QTOF | splash10-0006-9000000000-1388f0ca51c4e75f6b42 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 30V, Positive-QTOF | splash10-014i-9100000000-df32b49e057b6a5edd97 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-00di-0900000000-9651135645968dce9b22 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 40V, Positive-QTOF | splash10-014i-9000000000-07578727695a08ce800b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-0002-9200000000-f09400063d3927823895 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 40V, Negative-QTOF | splash10-0006-9000000000-8040399ca8ae40e84474 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-00di-0900000000-ef2ddbc13330f45e4bad | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Salicylamide 20V, Positive-QTOF | splash10-00di-6900000000-9f69f405679b9796ae17 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Salicylamide 10V, Positive-QTOF | splash10-000i-0900000000-c655cd261a8c661e33aa | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Salicylamide 20V, Positive-QTOF | splash10-00di-2900000000-ea12fb3cd63cf537aaa4 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Salicylamide 40V, Positive-QTOF | splash10-0ukc-9200000000-96adc1ac568629779c05 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Salicylamide 10V, Negative-QTOF | splash10-000i-1900000000-60bb0d72d85918c14248 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Salicylamide 20V, Negative-QTOF | splash10-000l-6900000000-166f967b97ba1ec9aa9f | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Salicylamide 40V, Negative-QTOF | splash10-0006-9000000000-7c31d3d2a8e030eb4234 | 2016-08-04 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|